Back to mobile site

Jefferies Raises Target On Integra LifeSciences (IART) to $37 After Q4 Results

February 24, 2012 11:47 AM EST
Get Alerts IART Hot Sheet
Price: $16.74 +0.90%

Rating Summary:
    8 Buy, 17 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Jefferies lifted its price target on Integra LifeSciences (NASDAQ: IART) from $30 to $37 following Q4 results. The firm maintained their Buy rating.

The firm comments, "4Q results, which were preannounced, showed end market headwinds as well as company-specific challenges, both of which management remains highly confident are transient in nature. Integra has worked through challenging times before and we expect the company will emerge from the latest with the longer term strategy largely intact."

Q1 EPS was cut from $0.67 to $0.63 but FY12 was lifted from $3.00 to $3.01.

For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.

Shares of Integra LifeSciences closed at $31.25 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co